Evidence map›Paper›PMID 37167218›Full record

ArticlePloS one2023

The calcium channel Orai1 is required for osteoblast development: Studies in a chimeric mouse with variable in vivo Runx-cre deletion of Orai-1.

Lisa J Robinson, Jonathan Soboloff, Irina L Tourkova, Quitterie C Larrouture, Kelechi M Onwuka, Dionysios J Papachristou, Scott Gross, Robert Hooper, Elsie Samakai, Paul F Worley and 4 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.8field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 6 institutions in 3 countries.

Lisa J RobinsonDepartments of Pathology, Anatomy and Laboratory Medicine, and of Microbiology, Immunology & Cell Biology, West Virginia University School of Medicine, Morgantown, WV, United States of America.
Jonathan SoboloffFels Cancer Institute for Personalized Medicine, Department of Cancer and Cellular Biology, Lewis Katz School of Medicine at Temple University, Philadelphia, PA, United States of America.
Irina L TourkovaDepartments of Pathology and of Cell Biology, The Pittsburgh VA Medical Center and the University of Pittsburgh, Pittsburgh, PA, United States of America.
Quitterie C LarroutureDepartments of Pathology and of Cell Biology, The Pittsburgh VA Medical Center and the University of Pittsburgh, Pittsburgh, PA, United States of America.
Kelechi M OnwukaDepartments of Pathology and of Cell Biology, The Pittsburgh VA Medical Center and the University of Pittsburgh, Pittsburgh, PA, United States of America.
Dionysios J PapachristouDepartments of Pathology and of Cell Biology, The Pittsburgh VA Medical Center and the University of Pittsburgh, Pittsburgh, PA, United States of America.
Scott GrossFels Cancer Institute for Personalized Medicine, Department of Cancer and Cellular Biology, Lewis Katz School of Medicine at Temple University, Philadelphia, PA, United States of America.
Robert HooperFels Cancer Institute for Personalized Medicine, Department of Cancer and Cellular Biology, Lewis Katz School of Medicine at Temple University, Philadelphia, PA, United States of America.
Elsie SamakaiFels Cancer Institute for Personalized Medicine, Department of Cancer and Cellular Biology, Lewis Katz School of Medicine at Temple University, Philadelphia, PA, United States of America.
Paul F WorleySolomon H. Snyder Department of Neuroscience, Johns Hopkins University School of Medicine, Baltimore, MD, United States of America.
Peng LiuInstitute of Comparative Molecular Endocrinology, Helmholtzstraße, Ulm, Germany.
Jan TuckermannInstitute of Comparative Molecular Endocrinology, Helmholtzstraße, Ulm, Germany.
Michelle R WittDepartments of Pathology, Anatomy and Laboratory Medicine, and of Microbiology, Immunology & Cell Biology, West Virginia University School of Medicine, Morgantown, WV, United States of America.ORCID 0000-0001-9483-8346
Harry C BlairDepartments of Pathology and of Cell Biology, The Pittsburgh VA Medical Center and the University of Pittsburgh, Pittsburgh, PA, United States of America.
Temple University · USUniversity of Pittsburgh Medical Center · USHelmholtz-Institute Ulm · DEWest Virginia University · USJohns Hopkins University · USUniversity of Patras · GR

Funding

Epithelial Osteoblast Function: The Role of Acid TransportR01AR076146 · NIAMS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI BLAIR, HARRY COLBERT, NELSON, DEBORAH J. · 2020 to 2024
$2.6M
Regulation of Osteoclastogenesis by CalciumR01AR065407 · NIAMS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI BLAIR, HARRY COLBERT, ROBINSON, LISA J · 2013 to 2017
$1.6M
Regulation of Osteoblasts by ACTH and VEGFI01BX002490 · VA · VETERANS HEALTH ADMINISTRATION · PI BLAIR, HARRY COLBERT · 2015 to 2025
–
BLRD VA I01 BX002490NIAMS NIH HHS R01 AR065407NIAMS NIH HHS R01 AR076146
6 · The paper itself

Abstract

The calcium-selective ion channel Orai1 has a complex role in bone homeostasis, with defects in both bone production and resorption detected in Orai1 germline knock-out mice. To determine whether Orai1 has a direct, cell-intrinsic role in osteoblast differentiation and function, we bred Orai1 flox/flox (Orai1fl/fl) mice with Runx2-cre mice to eliminate its expression in osteoprogenitor cells. Interestingly, Orai1 was expressed in a mosaic pattern in Orai1fl/fl-Runx2-cre bone. Specifically, antibody labeling for Orai1 in vertebral sections was uniform in wild type animals, but patchy regions in Orai1fl/fl-Runx2-cre bone revealed Orai1 loss while in other areas expression persisted. Nevertheless, by micro-CT, bones from Orai1fl/fl-Runx2-cre mice showed reduced bone mass overall, with impaired bone formation identified by dynamic histomorphometry. Cortical surfaces of Orai1fl/fl-Runx2-cre vertebrae however exhibited patchy defects. In cell culture, Orai1-negative osteoblasts showed profound reductions in store-operated Ca2+ entry, exhibited greatly decreased alkaline phosphatase activity, and had markedly impaired substrate mineralization. We conclude that defective bone formation observed in the absence of Orai1 reflects an intrinsic role for Orai1 in differentiating osteoblasts.

Indexed as

Calcium ChannelsCore Binding Factor Alpha 1 SubunitOsteoblastsAnimalsCalciumIntegrasesMiceMice, KnockoutORAI1 ProteinCalciumCalcium ChannelsCore Binding Factor Alpha 1 SubunitCre recombinaseIntegrasesORAI1 ProteinOrai1 protein, mouseRunx2 protein, mouse

Identifiers

PMID37167218
PMCPMC10174572
OpenAlexW4376226714

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.